Antitumor activity of some acylhydrazines.
D000215:Acylation; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D004353:Drug Evaluation, Preclinical; D006834:Hydrazines / Q000627:therapeutic use*; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010848:Picolinic Acids / Q000627:therapeutic use; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D006834:Hydrazines; D010848:Picolinic Acids